BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang A, Zheng Y, Zhu W, Yang L, Yang Y, Peng J. Melittin-Based Nano-Delivery Systems for Cancer Therapy. Biomolecules 2022;12:118. [DOI: 10.3390/biom12010118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Fahmy UA, Badr-Eldin SM, Aldawsari HM, Alhakamy NA, Ahmed OAA, Radwan MF, Eid BG, Sayed SRM, El Sherbiny GA, Abualsunun W. Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells. Drug Deliv 2022;29:1863-77. [PMID: 35708464 DOI: 10.1080/10717544.2022.2072544] [Reference Citation Analysis]
2 Akbarzadeh-Khiavi M, Torabi M, Olfati AH, Rahbarnia L, Safary A. Bio-nano scale modifications of melittin for improving therapeutic efficacy. Expert Opin Biol Ther 2022;:1-15. [PMID: 35687355 DOI: 10.1080/14712598.2022.2088277] [Reference Citation Analysis]
3 Maffeis V, Hürlimann D, Krywko‐cendrowska A, Schoenenberger C, Housecroft CE, Palivan CG. A DNA‐Micropatterned Surface for Propagating Biomolecular Signals by Positional on‐off Assembly of Catalytic Nanocompartments. Small. [DOI: 10.1002/smll.202202818] [Reference Citation Analysis]
4 Lyu M, Yazdi M, Lin Y, Höhn M, Lächelt U, Wagner E. Receptor-Targeted Dual pH-Triggered Intracellular Protein Transfer. ACS Biomater Sci Eng 2022. [PMID: 35802884 DOI: 10.1021/acsbiomaterials.2c00476] [Reference Citation Analysis]
5 Zhang Y, Chang L, Bao H, Wu X, Liu H, Gou S, Zhang J, Ni J. Constructing New Acid-Activated Anticancer Peptide by Attaching a Desirable Anionic Binding Partner Peptide. J Drug Target 2022;:1-26. [PMID: 35502656 DOI: 10.1080/1061186X.2022.2070627] [Reference Citation Analysis]
6 Li Y, Ruan S, Guo J, He Z, Xia Q, Wu T, Wang Z, Li Z, Hu H, Jing Q, Hou X, He Y, Zhang B, Feng N, Zhang Y. B16F10 Cell Membrane-Based Nanovesicles for Melanoma Therapy Are Superior to Hyaluronic Acid-Modified Nanocarriers. Mol Pharm 2022. [PMID: 35850109 DOI: 10.1021/acs.molpharmaceut.2c00212] [Reference Citation Analysis]